MedTrace Logo

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

NCT02178943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-10-29

No results posted yet for this study

Summary

Plasma donor-derived cell-free DNA (dd-cfDNA) is measured as a % of the total plasma cfDNA in association with the measurement of AlloMap, a non-invasive gene expression test to aid in heart transplant management.

Conditions

  • Cardiac Transplant Failure
  • Cardiac Transplant Rejection
  • Heart Diseases

Sponsors & Collaborators

  • CareDx

    lead INDUSTRY

Principal Investigators

  • James P Yee · CareDx Inc (formerly XDx Inc) Brisbane, CA

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2019-12-31
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02178943 on ClinicalTrials.gov